Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Phathom Pharmaceuticals (PHAT) Leases (2022 - 2025)

Phathom Pharmaceuticals (PHAT) has disclosed Leases for 4 consecutive years, with $2.6 million as the latest value for Q4 2025.

  • Quarterly Leases rose 324.63% to $2.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.6 million through Dec 2025, up 324.63% year-over-year, with the annual reading at $2.6 million for FY2025, 324.63% up from the prior year.
  • Leases for Q4 2025 was $2.6 million at Phathom Pharmaceuticals, down from $2.7 million in the prior quarter.
  • The five-year high for Leases was $2.7 million in Q3 2025, with the low at $388000.0 in Q1 2025.
  • Average Leases over 4 years is $1.7 million, with a median of $1.7 million recorded in 2022.
  • Peak annual rise in Leases hit 324.63% in 2025, while the deepest fall reached 69.3% in 2025.
  • Over 4 years, Leases stood at $2.3 million in 2022, then crashed by 35.51% to $1.5 million in 2023, then plummeted by 58.44% to $613000.0 in 2024, then surged by 324.63% to $2.6 million in 2025.
  • According to Business Quant data, Leases over the past three periods came in at $2.6 million, $2.7 million, and $873000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.